Skip to main content

Advertisement

Log in

Effects of Recombinant Amelogenin on Hydroxyapatite Formation In Vitro

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract.

To determine the role of amelogenin in the mineralization of dental enamel, the effects of the recombinant mouse amelogenin rM179 on in vitro hydroxyapatite formation have been studied. In a steady-state agarose gel assay for hydroxyapatite nucleation, rM179 lacked significant activity at concentrations up to 300 μg/ml. In an autotitration assay for inhibition of de novo hydroxyapatite formation, rM179 had no significant activity at concentrations up to 30 μg/ml. Using selected-area dark-field electron microscopy, it was shown that rM179, at concentrations up to 30 μg/ml, did not significantly affect the length of hydroxyapatite crystals formed in steady-state agarose gels. These findings suggest that amelogenins do not possess the specific crystal-modulating properties characteristic of certain acidic mineralized tissue proteins proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 2 September 1998 / Accepted: 17 February 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, G., Curtis, H., Grynpas, M. et al. Effects of Recombinant Amelogenin on Hydroxyapatite Formation In Vitro . Calcif Tissue Int 65, 226–231 (1999). https://doi.org/10.1007/s002239900688

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900688

Keywords

Navigation